Jared Watkin, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 3,466 shares at $45.39 ($157K) on 2017-03-01, disclosed to the SEC on 2017-03-02.
Scheduled sale ($157k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.46 | 2,496 | $113K | 72.0% |
| 2 | $45.39 | 970 | $44K | 28.0% |
| Total | $45.44 avg | 3,466 | $157K | 100% |
| Filing → |
| ABT | SELL | 2021-05-04 | $22.7M | — | Filing → |
| ABT | SELL | 2021-03-02 | $336K | — | Filing → |
| ABT | SELL | 2020-03-10 | $676K | — | Filing → |